Ensign Peak Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.8M | Sell |
|
|||||
|
2025
Q1 | $114M | Sell |
|
|||||
|
2024
Q4 | $111M | Buy |
|
|||||
|
2024
Q3 | $82.5M | Sell |
|
|||||
|
2024
Q2 | $86.1M | Sell |
|
|||||
|
2024
Q1 | $93.8M | Sell |
|
|||||
|
2023
Q4 | $269M | Sell |
|
|||||
|
2023
Q3 | $263M | Sell |
|
|||||
|
2023
Q2 | $270M | Buy |
|
|||||
|
2023
Q1 | $236M | Buy |
|
|||||
|
2022
Q4 | $123M | Buy |
|
|||||
|
2022
Q3 | $115M | Buy |
|
|||||
|
2022
Q2 | $103M | Buy |
|
|||||
|
2022
Q1 | $87M | Buy |
|
|||||
|
2021
Q4 | $64.9M | Sell |
|
|||||
|
2021
Q3 | $81.1M | Sell |
|
|||||
|
2021
Q2 | $122M | Buy |
|
|||||
|
2021
Q1 | $117M | Buy |
|
|||||
|
2020
Q4 | $128M | Buy |
|
|||||
|
2020
Q3 | $136M | Sell |
|
|||||
|
2020
Q2 | $181M | Sell |
|
|||||
|
2020
Q1 | $190M | Sell |
|
|||||
|
2019
Q4 | $177M | Buy |
|